Alterity Therapeutics Limited (ATH.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
As of 10:00AM AEST. Market open.
| Previous close | 0.0030 |
| Open | 0.0030 |
| Bid | 0.0020 x 0 |
| Ask | 0.0030 x 0 |
| Day's range | 0.0030 - 0.0030 |
| 52-week range | 0.0025 - 0.0085 |
| Volume | |
| Avg. volume | 14,870,302 |
| Market cap | 15.94M |
| Beta (5Y monthly) | 0.68 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Alterity (ATHE) Up on Interim Data From Advance MSA Study
Alterity (ATHE) posts positive interim data from the phase II ATH434-202 study evaluating its lead candidate ATH434 for treating patients with multiple system atrophy. Stock rises.
- Zacks
Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data
Data from a preclinical study shows that treatment with Alterity's (ATHE) lead candidate improved motor performance and general function in monkeys with experimentally-induced Parkinson's disease.
- Simply Wall St.
Alterity Therapeutics Limited's (ASX:ATH) CEO Compensation Is Looking A Bit Stretched At The Moment
Key Insights Alterity Therapeutics' Annual General Meeting to take place on 28th of November CEO David Stamler's total...
© 2024 Yahoo. All rights reserved.